🇺🇸 UTHR — United Therapeutics Corporation
Salud CompraPrecio actual
608,49 USD
Máx. histórico
608,49
0 días
Split 2:1 del 23/09/2009
Caída desde máximo
En máximo
Rango 52 semanas
432,53 – 614,23
Variación hoy
+1,19%
Cierre anterior
601,32
Rango de hoy
578,28 – 614,23
Volumen hoy
908.530
Peor caída histórica
-93,18%
12/07/2000 → 10/12/2001
Recuperado en 3311 días
Volatilidad anualizada ⓘ
46,95%
- Nombre completo
- United Therapeutics Corporation
- Divisa
- USD
- Mercado
- NasdaqGS
- Sector
- Salud
- Industria
- Drug Manufacturers - Specialty & Generic
- Empleados
- 1.400
- PER ⓘ
- 21,57 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 670,93 USD (puede no estar actualizado)
- Primera cotización
- 17/06/1999
- Precio actualizado
- hace 15 horas
United Therapeutics Corporation engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. It offers Tyvaso DPI, an inhaled dry powder via pre-filled and single-use cartridges; Nebulized Tyvaso, an inhaled solution via ultrasonic nebulizer; Remodulin (treprostinil) injection to treat patients with pulmonary arterial hypertension to diminish symptoms associated with exercise; Orenitram, a tablet dosage form of treprostinil, to delay disease progression and improve exercise capacity in PAH patients; and Adcirca, an oral PDE-5 inhibitor to enhance the exercise ability in PAH patients. It also markets and sells Unituxin (dinutuximab) injection, a monoclonal antibody for high-risk neuroblastoma; and Remunity Pump, which contains a pump and separate controller for Remodulin. In addition, it is involved in developing RemunityPRO Pump and Ralinepag for the treatment of PAH;and Nebulized Tyvaso, for the treatment of idiopathic pulmonary fibrosis, as well as xenografts, which are development-stage organ products. Further, it provides preclinical products, including EVLP/CLES, for lung transplant; UKidney, UHeart, UThymoKidney, a development-stage gene-edited porcine kidneys and hearts for xenotransplantation; ULobe, for allogeneic regenerative medicine; ULung, for autologous regenerative medicine; IVIVA Kidney, for autologous regenerative medicine; miroliver, for allogeneic regenerative medicine; and mirokidney, for allogeneic regenerative medicine. It has licensing and collaboration agreements with DEKA Research & Development Corp. to develop a semi-disposable system for the subcutaneous delivery of treprostinil; MannKind Corporation to develop and license treprostinil inhalation powder and the Dreamboat device; and Arena Pharmaceuticals, Inc. to develop Ralinepag. The company was founded in 1996 and is headquartered in Silver Spring, Maryland.
| Fecha | Ratio |
|---|---|
| 23/09/2009 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 13/04/2020 | 95,56 | 98,61 | 95,21 | 98,25 | +2,48% | 3,56% | 482.500 |
| 09/04/2020 | 97,11 | 98,00 | 95,19 | 95,87 | -0,75% | 2,89% | 453.200 |
| 08/04/2020 | 95,48 | 97,15 | 94,09 | 96,59 | +1,61% | 3,20% | 426.600 |
| 07/04/2020 | 97,31 | 98,10 | 93,48 | 95,06 | -0,73% | 4,75% | 794.600 |
| 06/04/2020 | 94,39 | 96,36 | 93,29 | 95,76 | +3,26% | 3,25% | 777.200 |
| 03/04/2020 | 92,63 | 94,97 | 91,86 | 92,74 | -0,84% | 3,36% | 724.500 |
| 02/04/2020 | 92,65 | 93,90 | 91,17 | 93,53 | -0,39% | 2,95% | 878.200 |
| 01/04/2020 | 93,35 | 96,48 | 89,89 | 93,90 | -0,98% | 7,06% | 583.400 |
| 31/03/2020 | 96,42 | 96,68 | 92,16 | 94,83 | -2,31% | 4,69% | 614.600 |
| 30/03/2020 | 92,83 | 97,25 | 90,68 | 97,07 | +6,30% | 7,08% | 542.400 |
| 27/03/2020 | 88,86 | 93,42 | 88,54 | 91,32 | -0,76% | 5,49% | 602.200 |
| 26/03/2020 | 91,29 | 94,95 | 89,50 | 92,02 | +1,63% | 5,97% | 516.200 |
| 25/03/2020 | 87,95 | 94,17 | 86,00 | 90,54 | +2,84% | 9,29% | 916.600 |
| 24/03/2020 | 87,91 | 89,98 | 84,71 | 88,04 | +4,87% | 5,99% | 633.500 |
| 23/03/2020 | 82,81 | 84,63 | 79,19 | 83,95 | +0,97% | 6,57% | 670.600 |
| 20/03/2020 | 83,72 | 86,86 | 81,67 | 83,14 | -0,57% | 6,20% | 714.200 |
| 19/03/2020 | 79,15 | 84,87 | 77,70 | 83,62 | +5,33% | 9,06% | 841.600 |
| 18/03/2020 | 75,91 | 82,29 | 75,58 | 79,39 | -1,45% | 8,84% | 793.500 |
| 17/03/2020 | 81,32 | 82,66 | 76,85 | 80,56 | +1,42% | 7,14% | 1.470.500 |
| 16/03/2020 | 83,69 | 86,78 | 78,56 | 79,43 | -13,58% | 9,82% | 1.053.200 |
| 13/03/2020 | 90,21 | 92,06 | 83,47 | 91,91 | +6,70% | 9,52% | 884.200 |
| 12/03/2020 | 88,19 | 91,64 | 84,89 | 86,14 | -8,35% | 7,65% | 1.510.200 |
| 11/03/2020 | 98,38 | 99,44 | 92,12 | 93,99 | -6,47% | 7,44% | 571.800 |
| 10/03/2020 | 94,93 | 100,99 | 92,61 | 100,49 | +10,08% | 8,83% | 807.000 |
| 09/03/2020 | 93,67 | 94,97 | 90,88 | 91,29 | -7,09% | 4,37% | 672.600 |
| 06/03/2020 | 99,99 | 101,17 | 96,11 | 98,26 | -2,92% | 5,06% | 1.257.200 |
| 05/03/2020 | 100,90 | 103,91 | 100,53 | 101,22 | -1,97% | 3,35% | 297.600 |
| 04/03/2020 | 102,50 | 103,38 | 99,53 | 103,25 | +3,03% | 3,76% | 555.100 |
| 03/03/2020 | 103,43 | 105,33 | 99,41 | 100,21 | -3,49% | 5,72% | 530.700 |
| 02/03/2020 | 103,15 | 104,13 | 99,50 | 103,83 | +0,84% | 4,49% | 644.400 |